Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine–DNA methyltransferase in hematopoietic cells

This publication has 42 references indexed in Scilit:

• Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis
  Blood, 2005
• Gene Transfer to Repopulating Human CD34+ Cells Using Amphotropic-, GALV-, or RD114-Pseudotyped HIV-1-Based Vectors from Stable Producer Cells
  Molecular Therapy, 2005
• Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy
  Blood, 2005
• Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection
  Gene Therapy, 2004
• Protection and selection for gene therapy in the hematopoietic system
  The Journal of Gene Medicine, 2004
• Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides
  Journal of Virology, 2004
• LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
  Science, 2003
• Targeting Survival
  Cell, 2003
• A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines
  The Journal of Gene Medicine, 2003
• Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates
  Blood, 2002